Growth Metrics

Armata Pharmaceuticals (ARMP) Accumulated Expenses: 2014-2017

Historic Accumulated Expenses for Armata Pharmaceuticals (ARMP) over the last 4 years, with Dec 2017 value amounting to $1.1 million.

  • Armata Pharmaceuticals' Accumulated Expenses rose 52.93% to $1.8 million in Q3 2018 from the same period last year, while for Sep 2018 it was $1.8 million, marking a year-over-year increase of 52.93%. This contributed to the annual value of $1.1 million for FY2017, which is 17.32% up from last year.
  • As of FY2017, Armata Pharmaceuticals' Accumulated Expenses stood at $1.1 million, which was up 17.32% from $895,000 recorded in FY2016.
  • In the past 5 years, Armata Pharmaceuticals' Accumulated Expenses registered a high of $1.1 million during FY2017, and its lowest value of $457,000 during FY2014.
  • Over the past 3 years, Armata Pharmaceuticals' median Accumulated Expenses value was $895,000 (recorded in 2016), while the average stood at $891,000.
  • Data for Armata Pharmaceuticals' Accumulated Expenses shows a peak YoY surged of 59.30% (in 2015) over the last 5 years.
  • Armata Pharmaceuticals' Accumulated Expenses (Yearly) stood at $457,000 in 2014, then soared by 59.30% to $728,000 in 2015, then grew by 22.94% to $895,000 in 2016, then increased by 17.32% to $1.1 million in 2017.